Ondine Biomedical, Inc.'s market cap is currently ―. The company's EPS TTM is p-0.059; its P/E ratio is -1.23; Ondine Biomedical, Inc. is scheduled to report earnings on May 16, 2024, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 22	Dec 21	Jun 21	Dec 20
Income Statement	-
Total Revenue	-	-	-	-
Gross Profit	-	-	-	-
EBIT	-	-	-	-
EBITDA	-	-	-	-
Net Income Common Stockholders	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	C$ 20.93M	C$ 30.36M	C$ 575.00K	C$ 626.00K
Total Assets	C$ 25.31M	C$ 34.14M	C$ 2.55M	C$ 2.63M
Total Debt	C$ 720.00K	C$ 739.00K	C$ 33.40M	C$ 31.46M
Net Debt	C$ -20.21M	C$ -29.63M	C$ 32.82M	C$ 30.83M
Total Liabilities	C$ 3.49M	C$ 4.48M	C$ 39.27M	C$ 36.46M
Stockholders Equity	C$ 21.82M	C$ 29.66M	C$ -36.70M	C$ -33.81M
Cash Flow	-
Free Cash Flow	-	-	-	-
Operating Cash Flow	-	-	-	-
Investing Cash Flow	-	-	-	-
Financing Cash Flow	-	-	-	-

Currency in CAD

Ondine Biomedical, Inc. Earnings and Revenue History

Income Statement >

Ondine Biomedical, Inc. Debt to Assets

Balance Sheet >

Ondine Biomedical, Inc. Cash Flow

Cash Flow >

Ondine Biomedical, Inc. Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing